IQVIA Holdings Inc. (IQV) stock
Close on Nov 12, 2026Market cap $44.68BP/E 32.9Yield –
IQVIA Holdings Inc. grew revenue 8.8% to $17.31B over the twelve months to Sep 30, 2026. Operating income rose 1.7% to $2.22B, moving the operating margin from 13.7% to 12.8%. Free cash flow was $2.08B, down 6.0% from a year earlier. At the latest close the market valued the company at $44.68B, 32.9 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $44.68B
- P/E ratio
- 32.9
- Price to sales
- 2.58
- Price to book
- 6.71
- Dividend yield
- –
- Free cash flow yield
- 4.65%
Fundamentals
- Revenue
- $17.31B
- Net income
- $1.39B
- EPS, diluted
- $8.23
- Free cash flow
- $2.08B
- Book value per share
- $39.88
- Diluted shares
- 167M
Trading
- Next earnings
- Feb 4, 2027 (estimated, before the open)
- Previous close
- $274.53
- Open
- $277.44
- Day's range
- $266.23 – $277.44
- Volume
- 1,041,121
- Average volume (20 days)
- 1,407,099
- Index membership
- S&P 500, Russell 1000, Russell 3000
- Beta (5 years)
- 1.16
- 52-week range
- $154.50 – $284.50
- RSI (14 days)
- 51.9
- Volatility (1 year)
- 40.6%
- Relative volume
- 0.73×
- WACC
- 9.0%
On 2 of our idea lists: Buyback cannibals, Superinvestor favorites
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2013, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | IQV | S&P 500 | Difference | IQV per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +3.4% | -2.7% | +6.1 pts | ||
| 3 months | +12.2% | -1.7% | +13.9 pts | ||
| Year to date | +20.3% | +11.9% | +8.4 pts | ||
| 1 year | +22.7% | +12.0% | +10.8 pts | ||
| 3 years | +38.3% | +78.2% | −39.8 pts | +11.4% | +21.2% |
| 5 years | +6.5% | +73.2% | −66.8 pts | +1.3% | +11.6% |
| 10 years | +251.5% | +309.6% | −58.2 pts | +13.4% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Iqvia filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- News
- Results
- News
- News
About Iqvia
Services-Commercial Physical & Biological Research
IQVIA provides clinical research services, healthcare intelligence, and commercial solutions to the life sciences and healthcare sectors. The company operates primarily through three reportable segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Its portfolio includes cloud-based software platforms, real-world evidence analytics, strategic consulting, end-to-end clinical trial management, laboratory services, and stakeholder engagement programs. IQVIA serves biotechnology, pharmaceutical, medical device, and consumer health companies, as well as healthcare providers, payers, government bodies, researchers, and pharmacies.
Company profile, executives and historyIqvia stock: common questions
What is Iqvia's stock price?
IQV closed at $271.11 on Nov 12, 2026, down 1.25% on the day. Over the past 52 weeks it traded between $154.50 and $284.50.
What is Iqvia's market cap?
Iqvia was worth $44.68B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is IQV's P/E ratio?
IQV trades at 32.9 times earnings, based on diluted earnings per share of $8.23 over the twelve months to Sep 30, 2026.
How much revenue does Iqvia make?
Iqvia reported revenue of $17.31B for the twelve months to Sep 30, 2026, up 8.8% from a year earlier.
Does Iqvia pay a dividend?
No. Iqvia has not paid a cash dividend over the last twelve months.
When does Iqvia report earnings next?
Iqvia is expected to report Q4 FY2026 results on Feb 4, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has IQV stock performed over the past year?
Including dividends, IQV returned +22.7% over the past year, against +12.0% for the S&P 500.
How many IQV shares are sold short?
3M shares were sold short at the latest FINRA report, 1.87% of the float, or 2.1 days of average trading volume.
Who are Iqvia's competitors?
Companies most similar to Iqvia by business, industry and size include ICLR, MEDP, CRL, INCY, LH.
See a number that looks wrong?